It’s still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.
Comms outreach efforts pass the test for Interpace
June 11, 2018
11:00 am
A combination of traditional and modern comms tactics help molecular diagnostic testing company Interpace craft messages that resonate with all key audiences.
Five things for pharma marketers to know: Monday, June 4, 2018
New study finds early-stage breast cancer may not need chemo; Merck’s Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior
Transparency may have taken a back seat on this diversity drive
MM&M/Publicis Health’s first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn’t feel like opening up about their diversity numbers.
Interview | Sam Cannizzaro, GSW, a Syneos Health company
Sam Cannizzaro, executive creative director at GSW, a Syneos Health company,discusses the agency’s response to the rapid pace of change in healthcare marketing.
How drugmakers are facing the entrance of consumer giants into healthcare
As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.
MM&M Hall of Femme 2018: The profiles
May 21, 2018
11:30 am
MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.
Meet the 2018 Women to Watch Honorees
May 21, 2018
11:30 am
MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.
Vanessa Thirion-Cullity, Novartis Oncology
May 21, 2018
11:30 am
Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.